Results 121 to 130 of about 69,645 (303)

Strontium Lactate in Hemophilia [PDF]

open access: green, 1907
NULL AUTHOR_ID
openalex   +1 more source

Factors Influencing Symptoms of Depression, Anxiety and Stress in Patients With Haemophilia

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Patients with haemophilia (PwH) often suffer from psychological symptoms such as depression or anxiety. To date, uncertainty exists about the determinants predicting worse psychological outcomes. Therefore, this study aimed to investigate the extent of depressive, anxiety and stress‐related symptoms in PwH compared to the healthy ...
Alexander Schmidt   +7 more
wiley   +1 more source

Multiple Comorbid Conditions among Middle-Aged and Elderly Hemophilia Patients: Prevalence Estimates and Implications for Future Care

open access: yesJournal of Aging Research, 2011
Introduction. Advances in hemophilia care and treatment have led to increases in the life expectancy among hemophiliacs. As a result, persons with hemophilia are reaching an older age and experiencing various age-related health conditions never seen ...
Aroub A. Khleif   +3 more
doaj   +1 more source

Measuring Physical Function Capacity in Persons With Haemophilia: A Systematic Review of Performance‐Based Methods

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Currently, physical health assessments in persons with haemophilia focus on bleed‐related events and after‐effects. The aim of the systematic review was to review and apply standardised criteria to evaluate reliability, responsiveness and construct validity of performance‐based instruments evaluating physical capability in persons
Catherine Holdsworth   +9 more
wiley   +1 more source

Safety and Use of Eptacog Beta 225 µg/kg in Patients With Haemophilia A or B With Inhibitors

open access: yesHaemophilia, EarlyView.
Introduction Eptacog beta is an activated recombinant human factor VII bypassing agent approved for treating bleeding episodes (BEs) in patients aged ≥12 years with haemophilia A or B with inhibitors. Two initial dose regimens (IDRs) of either 75 or 225 µg/kg, followed by 75 µg/kg, are approved.
Manuel Carcao   +7 more
wiley   +1 more source

Epidemiological Profile of Hemophilia in Baghdad-Iraq

open access: yesInquiry: The Journal of Health Care Organization, Provision, and Financing, 2019
Hemophilia is an inherited bleeding disorder that mainly affects males. Globally, there are about 400 000 people with hemophilia and only 25% of them receive adequate treatment.
Kamal Abdul Razzaq Kadhim MBChB   +2 more
doaj   +1 more source

Alternative Immunosuppression in Acquired Haemophilia A

open access: yes
Haemophilia, EarlyView.
Jayna Mistry   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy